Serum visfatin as predictive marker of cardiometabolic risk in women with polycystic ovary syndrome
Conclusion Serum visfatin levels could discriminate PCOS from healthy control and T2DM from NGT PCOS women. Moreover, vesfatin was positive correlated to cardio-metabolic risk factors. Interestingly, the sensitivity and specificity power of vesfatin were high. Thus, it could be early predicting of cardio-metabolic risks among PCOS women and might be useful in therapeutic intervention in future.
Source: Middle East Fertility Society Journal - Category: Reproduction Medicine Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Heart | Insulin | Middle East Health | Ovaries | Polycystic Ovary Syndrome | Reproduction Medicine | Study | Women